Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
By: Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, Gabriela Z. L. Ruiz, Letícia Maria M. Rabelo, Alison R. Tompsett, Antonio Luiz P. Ribeiro, Klas-Göran Sahlen, Bruno R. Nascimento and On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators
DOI: https://doi.org/10.5334/gh.529 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 16, 2019
Accepted on: Dec 18, 2019
Published on: Feb 20, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, Gabriela Z. L. Ruiz, Letícia Maria M. Rabelo, Alison R. Tompsett, Antonio Luiz P. Ribeiro, Klas-Göran Sahlen, Bruno R. Nascimento, On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.